Previous
Previous

Surface Oncology Announces Promising SRF388 Monotherapy Data in Non-Small Cell Lung Cancer (NSCLC), Opening Second Stage of Monotherapy Trial and NSCLC Pembrolizumab Combination Cohort

Next
Next

VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures